A cost-effective aptasensor capable of early diagnosis and monitoring of Alzheimer's disease with the rapid analysis of beta-amyloid peptide 1

A cost-effective aptasensor capable of early diagnosis and monitoring of Alzheimer's disease with the rapid analysis of beta-amyloid peptide 1–40

Published:2023 Issue:2 Volume:2 Page:409-417
ISSN:2635-0998
Container-title:Sensors & Diagnostics
language:en
Short-container-title:Sens. Diagn.

Author:

Khang Ashley¹,Idegwu Nnebuefe¹,Lee Ji Hoon¹^ORCID

Affiliation:

1. Luminescent MD, LLC, Hagerstown, MD, 21742, USA

Abstract

A cost-effective biosensor with guanine chemiluminescence detection capable of sensing trace levels of beta-amyloid peptide 1–40 was developed for the early diagnosis and accurate monitoring of Alzheimer's disease (AD).

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2023/SD/D2SD00162D

Reference41 articles.

1. One hundred years of Alzheimer's disease and the neglected second lesson of Aloïs Alzheimer on multicausality in dementia

2. Biosensing: The best alternative for conventional methods in detection of Alzheimer's disease biomarkers

3. A Systematic Review of Delirium Biomarkers and Their Alignment with the NIA‐AA Research Framework

4. Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau

5. A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA-mediated chemiluminescence bioassays;TrAC Trends in Analytical Chemistry;2024-06

2. A Rapid, Wash-Free, Label-Free Dual-Aptasensor for Sensitive C-Reactive Protein Detection Utilizing a G-Quadruplex Dnazyme;2024

3. Aptasensors: employing molecular probes for precise medical diagnostics and drug monitoring;Bioanalysis;2023-10-17